Is Cirrhotic Cardiomyopathy Related to Cirrhosis Severity?
Rambam Maimonides Medical Journal · 29.01.2023 · 14 (1) · e0001
DOI: 10.5041/rmmj.10488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rambam Maimonides Medical Journal, online erschienen am 29.01.2023. Verfasst von Subhash Chandra Dash und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Institute of Medical Sciences & SUM Hospital, Bhubaneswar, India. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
Cirrhotic cardiomyopathy (CCM) is associated with increased morbidity and mortality in patients with liver cirrhosis. Yet, it remains an under-diagnosed entity. Further, its relation to the severity of cirrhosis is contradictory. We conducted this study on an Indian population to determine the cardiac dysfunctions in cirrhosis of the liver and correlations with etiologies and cirrhosis severity.
Methods
This study enrolled patients with diagnosed liver cirrhosis without any cardiac disease or conditions affecting cardiac function. All participants were evaluated clinically, electrocardiographically, and echocardiographically. Cirrhosis severity was assessed by scores from the Model for End-stage Liver Disease (MELD) and Child–Turcotte–Pugh (CTP) tests. Cirrhotic cardiomyopathy was defined as diastolic dysfunction and/or systolic dysfunction with QT prolongation.
Results
Ninety-six patients were evaluated, and CTP-A stage of cirrhosis was found in 23 (24%), CTP-B in 42 (43.8%), and CTP-C in 31 (32.3%) cases. Systolic dysfunction was most frequent (P=0.014), and left ventricular ejection fraction was significantly reduced (P=0.001) in CTP-C stage of cirrhosis. Cirrhotic cardiomyopathy was found in 39.6% (n=38) of patients; CCM patients had significantly higher CTP scores (9.6±2.6 versus 8.3±2.3, P=0.012) as well as MELD scores (19.72±4.9 versus 17.41±4.1, P=0.015) in comparison to patients without CCM.
Conclusion
Cirrhotic cardiomyopathy has a positive relationship with the severity of cirrhosis. Systolic function declines with the severity of cirrhosis, and overt systolic dysfunction can be present, particularly in the advanced stage of cirrhosis of the liver.
Autor:innen und Institutionen
- Department of General Medicine, Institute of Medical Sciences & SUM Hospital, Bhubaneswar, India.
- Department of General Medicine, Chalmeda Ananda Rao Institute of Medical Sciences, Telangana, India.
- Department of Cardiology, Institute of Medical Sciences & SUM Hospital, Bhubaneswar, India.
- Department of Neurology, Jawaharlal Nehru Medical College, Karnataka, India.
Zitieren
APA
Dash, S. C., Rajesh, B., Behera, S. K., Sundaray, N. K., & Patil, P. (2023). Is Cirrhotic Cardiomyopathy Related to Cirrhosis Severity?. Rambam Maimonides Medical Journal, 14(1), e0001. https://doi.org/10.5041/rmmj.10488
Vancouver
Dash SC, Rajesh B, Behera SK, Sundaray NK, Patil P. Is Cirrhotic Cardiomyopathy Related to Cirrhosis Severity?. Rambam Maimonides Medical Journal. 2023;14(1):e0001. doi:10.5041/rmmj.10488
BibTeX
@article{Dash2023,
author = {Dash, Subhash Chandra and Rajesh, Beeravelli and Behera, Suresh Kumar and Sundaray, Naba Kishore and Patil, Praveen},
title = {Is Cirrhotic Cardiomyopathy Related to Cirrhosis Severity?},
journal = {Rambam Maimonides Medical Journal},
year = {2023},
volume = {14},
number = {1},
pages = {e0001},
doi = {10.5041/rmmj.10488}
}
EUVIMED